NBE-Therapeutics AG

📍 Basel, Switzerland👥 38 employees💰 Last funded Oct 2020
Biotechnology Research🌐 nbe-therapeutics.com
Website LinkedIn
At NBE Therapeutics we strive to develop best-in-class oncology treatments to increase survival and improve quality of life for cancer patients worldwide. Through our highly innovative novel in-house developed technologies, we have created a next generation antibody drug conjugate platform targeting solid tumors. Our platform allows us to develop targeted medicines, that through a long-lasting immune oncology effect, could reduce or even eradicate tumors. Our dedicated international team has been able to create a pipeline of ADC product candidates in various stages of development to enter clinical phases to create better treatments for cancer patients in need of more selective drugs.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Germany
2
Frequently asked questions
Who invested in NBE-Therapeutics AG?
NBE-Therapeutics AG has 2 investors on record on gritt.io.
When did NBE-Therapeutics AG last raise funding?
The most recent investment in NBE-Therapeutics AG recorded on gritt.io was in October 2020.
What industry is NBE-Therapeutics AG in?
NBE-Therapeutics AG operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is NBE-Therapeutics AG based?
NBE-Therapeutics AG is headquartered in Basel, Switzerland.